• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gland Pharma Ltd Pharmaceuticals - Indian - Formulations

  • MNC Associate
  • BSE Code : 14546.0
  • ISIN : INE068V01023
1,978.50 -86 (-4.18%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,951.50

  • Today’s High

    2,062.00

  • Open

    2,060.00

  • Perv Close

    2,064.80

  • 52W Low

    1,277.80

  • 52W High

    2,220.95

Key Indicators

  • P/E(TTM)

    29.92

  • Mar.Cap (₹Cr.)

    32,597.06

  • Div & Yield %

    0.91

  • Book Value(₹)

    592.09

  • Debt-Equity Ratio

    -4.18

  • AGM Date

    01-Aug-2025

  • EPS

    66.14

  • P/E Ratio

    29.92

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    32,597.06

  • RONW (%)

    9.26

  • ROCE (%)

    13.44

Score Board

  • Equity (₹ in Cr.)

    16.48

  • BV (₹)

    592.10

  • Sales( ₹ in Cr.)

    4,116.15

  • NP (in Cr.)

    1,088.78

  • NP Var(%)

    4.0

  • Div%

    1800.0

  • CPS (₹)

    76.40

  • EPS (₹)

    66.10

  • Traded Value (₹ in Lakhs)

    32,608.59

  • 52 Week High

    2,220.95

  • 52 Week Low

    1,277.80

  • Price BSE

    1979.0

  • Price NSE

    1,979.00

  • Market Capital( in Cr.)

    32,608.59

  • P/C Ratio

    25.90

  • P/E Ratio

    29.90

  • Price Vs.BV

    66.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 4,116.15 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,116.15 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24
Other Income 215.08 166.67 240.46 223.94 134.78 139.17
Stock Adjustments -130.25 -87.43 46.92 -36.69 273.49 6.90
Total Income 4,200.98 4,246.67 3,903.91 4,587.96 3,871.15 2,779.31
EXPENDITURE :            
Raw Materials 1,600.35 1,732.88 1,732.34 2,072.53 1,765.36 1,108.93
Power and Fuel Cost 120.38 117.20 124.84 95.05 74.59 78.50
Employee Cost 439.02 409.95 399.70 338.57 311.36 277.66
Other Manufacturing Expenses 188.89 186.92 153.84 137.19 130.84 102.23
Selling and Administration Expenses 155.54 175.97 189.65 177.43 128.44 98.54
Miscellaneous Expenses 39.10 48.31 100.99 32.61 23.51 18.82
Employee Benefit Expenses 439.02 409.95 399.70 338.57 311.36 277.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,543.29 2,671.22 2,701.35 2,853.38 2,434.10 1,684.68
Operating Profit 1,657.70 1,575.44 1,202.55 1,734.58 1,437.04 1,094.63
Interest 22.84 7.84 7.41 5.24 3.41 7.18
Gross Profit 1,634.86 1,567.60 1,195.14 1,729.34 1,433.63 1,087.45
Depreciation 169.27 162.11 146.74 110.30 98.78 94.59
Profit Before Tax 1,465.59 1,405.49 1,048.40 1,619.04 1,334.85 992.86
Current Tax 366.71 337.49 275.38 392.88 337.73 251.83
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 9.12 24.68 -2.80 14.01 0.12 -31.82
Reported Net Profit 1,089.75 1,043.33 775.83 1,212.16 997.01 772.86
Extraordinary Items 0.97 -0.39 -39.55 3.22 0.02 12.99
Adjusted Net Profit 1,088.78 1,043.72 815.38 1,208.94 996.99 759.87
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 7,054.03 6,010.70 5,234.88 4,022.72 3,025.72 2,252.86
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 329.50 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 7,814.28 7,054.03 6,010.70 5,234.88 4,022.72 3,025.72
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,800.00 2,000.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 18.00 20.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 66.14 63.34 47.11 73.78 60.95 49.88
Earnings Per Share(Adj)-Unit Curr 66.14 63.34 47.11 73.78 60.95 -
Book Value 592.08 546.13 482.90 435.68 360.86 235.32
Book Value(Adj)-Unit Curr 592.08 546.13 482.90 435.68 360.86 -

Shareholding Pattern

  • Promoter Group

    51.83%

  • Public Share Holding

    48.17%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 85,393,934 51.83 85,393,934 5
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 85,393,934 51.83 85,393,934 5
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 100 0.00 100 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12,174,662 7.39 12,174,662 167
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,085,042 1.27 2,085,042 8
Mutual Funds / UTI 50,524,658 30.67 50,524,658 23
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,513,236 0.92 1,513,236 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 66,297,698 40.24 66,297,698 212
2] Non Institution
Bodies Corporate 7,763,124 4.71 1,763,124 336
Clearing Members 7 0.00 7 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 333,379 0.20 333,379 2,057
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 127,337 0.08 127,337 1,636
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,000,000 0.61 1,000,000 1
Individuals holding nominal share capital up to Rs. 1 lakh 3,797,985 2.31 3,797,985 106,387
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,064,791 7.93 7,064,791 110,454
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 164,756,423 100.00 158,756,423 110,671

Company Background

Gland Pharma LtdPharmaceuticals - Indian - Formulations

  • Gland Pharma Ltd
  • BSE Code : 14546.0
  • ISIN : INE068V01023

  • Incorporation Year

    1978

  • Registered Office

    Sy No 143-148 150&151 Nr Gandi
    X Roads D P Pally Dundigal, Hyderabad,
    Telangana-500043

  • Telephone

    91-40-30510999

  • FAX

    91-40-30510800

  • Chairman

    Yiu Kwan Stanley Lau

  • Managing Director

    SRINIVAS SADU

  • Company Secretary

  • Auditor

    Deloitte Haskins & Sells

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gland Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gland Pharma 1,979.20 4,331.22 4,116.15 29.92 15.83
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10